Stocks Health care BMEA
NASDAQ · Health careBiomea Fusion, Inc. (BMEA)
It posted a net loss of $32.5M. At June 30, 2026 it held $34.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Biomea Fusion, Inc.
- Net worth
- Biomea Fusion, Inc. has a market value (market cap) of $43.1M at the latest share price, and shareholders' equity of $12.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $70.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What Biomea Fusion, Inc. does
Biomea Fusion, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BMEA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$61.8M | -$1.18 | n/a |
| 2024 | n/a | -$138.4M | -$3.83 | -$120.3M |
| 2023 | n/a | -$117.3M | -$3.44 | -$100M |
| 2022 | n/a | -$81.8M | -$2.80 | -$63.4M |
| 2021 | n/a | -$41.6M | -$1.74 | -$38.6M |
| 2021 | n/a | -$5.3M | -$0.51 | -$4.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Biomea Fusion, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026Other event 8-K
- August 5, 2026
- August 5, 2026Exhibits 8-K
- June 11, 2026
- May 11, 2026
- May 11, 2026
- April 28, 2026
- April 27, 2026Proxy statement DEF 14A
- April 27, 2026
- March 24, 2026
Insider trades
What the people running Biomea Fusion, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| December 11, 2025 | Erdtmann Rainer MSee Remarks, Director | Bought | 30,000 | $43K |
| December 2, 2025 | Hitchcock Michael J.M.Interim CEO, Director | Bought | 100,000 | $99.2K |
| December 1, 2025 | Erdtmann Rainer MSee Remarks, Director | Bought | 10,000 | $10.5K |
| November 28, 2025 | Erdtmann Rainer MSee Remarks, Director | Bought | 40,000 | $44.1K |
Who owns BMEA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| CVI Investments, Inc.13G, passive with 1 related filers | 9.9% | February 17, 2026 |
| Blue Owl Capital Holdings LP13G, passive | 5.92% | February 12, 2026 |
| Janus Henderson Group PLC13G, passive | 5% | December 8, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 61 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 8,814,946 | +1,587 |
| Vanguard Capital Management LLC | 2,829,927 | +232,627 |
| Marshall Wace, Llp | 2,049,802 | +851,251 |
| Aisling Capital Management LP | 2,048,757 | 0 |
| Renaissance Technologies LLC | 1,455,474 | +142,676 |
| Fideuram - Intesa Sanpaolo Private Banking S.P.A. | 723,176 | +166,140 |
| BlackRock, Inc. | 715,445 | +74,010 |
| Geode Capital Management, LLC | 708,854 | +160,668 |
| Susquehanna International Group, Llp | 612,735 | -17,130 |
| Mariner, LLC | 594,726 | -59,852 |
| Jane Street Group, LLC | 458,289 | +182,634 |
| UBS Group AG | 444,728 | -70,827 |
| XTX Topco Ltd | 406,879 | -123,663 |
| Two Sigma Investments, LP | 384,459 | -4,237 |
| Morgan Stanley | 367,021 | +20,279 |
| Vanguard Fiduciary Trust Co | 338,345 | +2,230 |
| MAI Capital Management | 289,100 | +200,000 |
| State Street Corp | 257,315 | +49,300 |
| LMR Partners LLP | 200,000 | 0 |
| Northern Trust Corp | 128,526 | -80,439 |
Insiders
2 insiders reported holding 838,027 shares in total, about $458.4K at the last price.
| Holder | Shares |
|---|---|
| Erdtmann Rainer MSee Remarks, Director | 723,027 |
| Hitchcock Michael J.M.Interim CEO, Director | 115,000 |
Questions about BMEA
What does Biomea Fusion, Inc. do?
Biomea Fusion, Inc. is a company in the Health care sector, listed on NASDAQ as BMEA. Its shares trade on NASDAQ under the ticker BMEA.
What is Biomea Fusion, Inc.'s net worth?
Biomea Fusion, Inc. has a market value (market cap) of $43.1M at the latest share price, and shareholders' equity of $12.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Biomea Fusion, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $32.5M.
When did Biomea Fusion, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 22, 2026.
Similar companies
Compare BMEA with
Follow BMEA
Get an email when Biomea Fusion, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Biomea Fusion, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.